Concepedia

Author

María Lagarde

Hospital Universitario 12 De OctubreORCID

Also Known As

Alicia Gómez-Sanz, D. McMaster, David Rial, F Pulido, F. Chaves, J de la Torre, Javier Díaz-Arias, L Bermejo Plaza, M LAGARDE, M Lagarde

79

Publications

960

Citations

17

H-Index

11

Concepts

All Affiliations

Hospital Universitario 12 De OctubreHospital Universitario La PazHospital Universitario Ramón y CajalInstituto de Salud Carlos IIIHospital Clínico San Carlos
ML

About

María Lagarde is an author at Hospital Universitario 12 De Octubre specializing in medicine, cell biology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

39

2

Biochemistry

1

1

16

3

Cell Biology

1

1

23

4

Immunology

1

1

23

5

Microbiology

1

1

16

María Lagarde

×

14

Publications

481

Citations

13

H-Index

YearCitations

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde,

Clinical Infectious Diseases

2017

102

Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia

Oriol Gasch, Mariana Camoez, M.Á. Domínguez,

Journal of Antimicrobial Chemotherapy

2013

61

Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)

Sergio Serrano‐Villar, María Lagarde, Jorge F. Vázquez‐Castellanos,

Clinical Infectious Diseases

2018

60

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus–Infected Patients With Nonalcoholic Fatty Liver Disease

Juan Macı́as, M.J. Mancebo, Dolores Merino,

Clinical Infectious Diseases

2017

56

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Javier Martínez‐Sanz, Jorge Díaz-Álvarez, Marta Rosas Cancio-Suárez,

EBioMedicine

2023

32

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

Inés Suárez‐García, Belén Alejos, Víctoria Hernando,

Journal of Antimicrobial Chemotherapy

2023

26

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

Ignacio Valero, Alicia González-Baeza, Miriam Estébanez,

PLoS ONE

2013

24

The Impaired in Vitro Production of Interleukin-2 in HIV Infection Is Negatively Correlated to the Number of Circulating CD4+ DR+ T Cells and Is Reversed by Allowing T Cells to Rest in Culture: Arguments for in Vivo CD4+ T Cell Activation

O Lees, Soumia Ramzaoui, D. Gilbert,

Clinical Immunology and Immunopathology

1993

23

Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery

Sergio Serrano‐Villar, Sergio Sánchez-Carrillo, Alba Talavera-Rodríguez,

The Journal of Infectious Diseases

2020

20

A Prospective Cohort Study of Neurocognitive Function in Aviremic HIV-Infected Patients Treated With 1 or 3 Antiretrovirals

Ignacio Valero, Alicia González-Baeza, Miriam Estébanez,

Clinical Infectious Diseases

2014

19

Page 1